197 related articles for article (PubMed ID: 17074266)
61. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
[TBL] [Abstract][Full Text] [Related]
62. Different behaviours of promoters in Mycobacterium tuberculosis H37Rv and H37Ra.
Dokladda K; Billamas P; Palittapongarnpim P
World J Microbiol Biotechnol; 2015 Feb; 31(2):407-13. PubMed ID: 25556328
[TBL] [Abstract][Full Text] [Related]
63. Isocitrate lyase: a potential target for anti-tubercular drugs.
Sharma R; Das O; Damle SG; Sharma AK
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):114-23. PubMed ID: 23506018
[TBL] [Abstract][Full Text] [Related]
64. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
[TBL] [Abstract][Full Text] [Related]
65. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG
J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116
[TBL] [Abstract][Full Text] [Related]
66. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
[TBL] [Abstract][Full Text] [Related]
67. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery.
Christophe T; Ewann F; Jeon HK; Cechetto J; Brodin P
Future Med Chem; 2010 Aug; 2(8):1283-93. PubMed ID: 21426019
[TBL] [Abstract][Full Text] [Related]
68. RegX3 Controls Glyoxylate Shunt and Mycobacteria Survival by Directly Regulating the Transcription of Isocitrate Lyase Gene in
Xu Y; You D; Ye BC
ACS Infect Dis; 2021 Apr; 7(4):927-936. PubMed ID: 33663204
[TBL] [Abstract][Full Text] [Related]
69. Solvent isotope-induced equilibrium perturbation for isocitrate lyase.
Quartararo CE; Hadi T; Cahill SM; Blanchard JS
Biochemistry; 2013 Dec; 52(51):9286-93. PubMed ID: 24261638
[TBL] [Abstract][Full Text] [Related]
70. Antimicrobial antibodies by phage display: Identification of antibody-based inhibitor against mycobacterium tuberculosis isocitrate lyase.
Ch'ng ACW; Schepergerdes L; Choong YS; Hust M; Lim TS
Mol Immunol; 2022 Oct; 150():47-57. PubMed ID: 35987135
[TBL] [Abstract][Full Text] [Related]
71. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence.
Muñoz-Elías EJ; Upton AM; Cherian J; McKinney JD
Mol Microbiol; 2006 Jun; 60(5):1109-22. PubMed ID: 16689789
[TBL] [Abstract][Full Text] [Related]
72. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database.
Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS
J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452
[TBL] [Abstract][Full Text] [Related]
73. Mycobacterium tuberculosis genes induced during infection of human macrophages.
Dubnau E; Fontán P; Manganelli R; Soares-Appel S; Smith I
Infect Immun; 2002 Jun; 70(6):2787-95. PubMed ID: 12010964
[TBL] [Abstract][Full Text] [Related]
74. Regulation of the
Ko EM; Kim JY; Lee S; Kim S; Hwang J; Oh JI
J Bacteriol; 2021 Nov; 203(23):e0040221. PubMed ID: 34516281
[TBL] [Abstract][Full Text] [Related]
75. Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux.
Matt U; Selchow P; Dal Molin M; Strommer S; Sharif O; Schilcher K; Andreoni F; Stenzinger A; Zinkernagel AS; Zeitlinger M; Sander P; Nemeth J
Int J Antimicrob Agents; 2017 Jul; 50(1):55-62. PubMed ID: 28506804
[TBL] [Abstract][Full Text] [Related]
76. Ursolic Acid Activates Intracellular Killing Effect of Macrophages During Mycobacterium tuberculosis Infection.
Podder B; Jang WS; Nam KW; Lee BE; Song HY
J Microbiol Biotechnol; 2015 May; 25(5):738-44. PubMed ID: 25406534
[TBL] [Abstract][Full Text] [Related]
77. A chemical proteomics approach to profiling the ATP-binding proteome of Mycobacterium tuberculosis.
Wolfe LM; Veeraraghavan U; Idicula-Thomas S; Schürer S; Wennerberg K; Reynolds R; Besra GS; Dobos KM
Mol Cell Proteomics; 2013 Jun; 12(6):1644-60. PubMed ID: 23462205
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages.
Dharra R; Radhakrishnan VS; Prasad T; Thakur Z; Cirillo JD; Sheoran A; Pandey AK; Kulharia M; Mehta PK
Sci Rep; 2019 Jul; 9(1):10084. PubMed ID: 31300732
[TBL] [Abstract][Full Text] [Related]
79. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
[TBL] [Abstract][Full Text] [Related]
80. A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viability.
Larsson MC; Lerm M; Ängeby K; Nordvall M; Juréen P; Schön T
J Microbiol Methods; 2014 Nov; 106():146-150. PubMed ID: 25194234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
